PHARMALAB ApS: Financial statements 2023
CVR: 33058101
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMALAB ApS (CVR 33058101) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -42,256 and a net result of DKK -31,505 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK -107,589. The company had 1 employee in the financial year.
- Gross Profit
- DKK -42,256
- Profit/Loss
- DKK -31,505
- Equity
- DKK -107,589
- Total Assets
- DKK 165,312
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -42 t. | -32 t. | -108 t. | 1 |
| 2022 | - | 9 t. | -17 t. | -76 t. | 1 |
| 2021 | - | -17 t. | -24 t. | -59 t. | - |
| 2020 | - | -10 t. | -8 t. | -35 t. | - |
| 2019 | - | -28 t. | -23 t. | -27 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMALAB ApS has published its annual report for 2022. Gross profit came to DKK 8,548, and the net result was DKK -16,738.
About PHARMALAB ApS
PHARMALAB ApS was a Danish company of the type Anpartsselskab based in Hårlev, founded in 2010. The company has been dissolved on 18 March 2025. The company was registered under the industry Fremstilling af andre maskiner til generelle formål i.a.n.. According to the 2023 annual report, the company had an average of 1 employee. In 2023, the company reported a gross profit of DKK -42,256 and a net result of DKK -31,505 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK -107,589.